Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 52 of 59, showing 10 Applications out of 584 total, starting on record 511, ending on 520

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

511.

ECCT/14/07/01  
    POST STABILIZATION VERSUS URGENT START OF HAART IN HIV-1 INFECTED CHILDREN WITH SEVERE COINFECTION   
Principal Investigator(s)
1. Grace John-Stewart
Site(s) in Kenya
1. Kenyatta National Hospital (Nairobi City county)
2. Jaramogi Odinga Teaching and Referral Hospital (Kisumu county)
3. Kisumu East District Hospital (Kisumu county)
 
21-10-2014 View

512.

ECCT/14/06/01   ACTG -5279
    Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals with Latent Tuberculosis Infection   
Principal Investigator(s)
1. Dr. Kevin N/A Cain
Site(s) in Kenya
1. KEMRI/WRP CRS (Kericho county)
2. Moi University Clinical Research Center CRS ()12601 (Uasin Gishu county)
 
30-06-2014 View

513.

ECCT/14/05/03   Invivo II study
    Therapeutic efficacy of dihydroartemisinin piperaquine and artemether lumefantrine for the treatment of uncomplicated malaria  in Kisumu County, Western Kenya   Therapeutic efficacy of dihydroartemisinin piperaquine and artemether lumefantrine for the treatment of uncomplicated malaria  in Kisumu County, Western Kenya   
Principal Investigator(s)
1. Ben Andagalu
Site(s) in Kenya
Kombewa Clinical Research Center
 
14-07-2014 View

514.

ECCT/14/05/02   Invivo I study
    In vivo and in vitro efficacy of artemisinin combination therapy in Kisumu County, Western Kenya.   
Principal Investigator(s)
1. Ben Andagalu
Site(s) in Kenya
Kombewa Clinical Research Center
 
14-07-2014 View

515.

ECCT/14/04/01   REACH Trial
    REALIZING EFFECTIVENESS ACROSS CONTINENTS WITH HYDROXYUREA (REACH):  A PHASE I/II PILOT STUDY OF HYDROXYUREA FOR CHILDREN WITH SICKLE CELL ANAEMIA.   
Principal Investigator(s)
1. Thomas Neil Williams
Site(s) in Kenya
Kilifi County Hospital
 
07-07-2014 View

516.

ECCT/14/03/02   Rivaroxaban on prevention of stroke and non-central nervous system systemic embolism in patients with non valvular atrial fibrillation
    XANTUS-EL, Xarelto on prevention of stroke and non-central nervous system systemic embolism in patients with non valvular atrial fibrillation - a non interventional study, XA 1206 (IMPACT No. 16691)       
Principal Investigator(s)
1. Warshow Majid Mbarak
Site(s) in Kenya
1. MP Shah Hospital (Nairobi City county)
 
16-11-2012 View

517.

ECCT/14/03/01  
    Comparison of School and Community-based Mass Drug    Administration Delivery Strategies for Control of Schistosoma mansoni Infections in Western Kenyan in Areas with > 25% Prevalence       
Principal Investigator(s)
1. Mwinzi Ngina Mwinzi
Site(s) in Kenya
Nyanza region
 
30-06-2014 View

518.

ECCT/14/02/03  
    A Phase 1/2 Randomized, Double-Blind, Dose-Finding Study to Assess the Safety, Tolerability, and Immunogenicity of Inactivated  Streptococcus pneumoniae Whole Cell Vaccine Formulated with Alum (PATH-wSP) in Healthy Kenyan Young Adults and PCV-Primed Toddlers (12-15 Months of Age)       
Principal Investigator(s)
1. Nekoye Namungu Otsyula
2. Walter Otieno
Site(s) in Kenya
Kenya Medical Research Institute (KEMRI)/Walter Reed Project, Kombewa Clinical Research Center
 
14-02-2014 View

519.

ECCT/14/02/02   Integrated community case management
    Evaluating integrated community case management of pneumonia, malaria and diarrhoea among children under 5 years in Homabay County, Kenya.   
Principal Investigator(s)
1. Maricianah Atieno Onono
Site(s) in Kenya
Homabay County
 
21-05-2013 View

520.

ECCT/14/02/01  
    integrated community case management (iCCM) in Homabay County, Kenya   
Principal Investigator(s)
1. Maricianah Atieno Onono
Site(s) in Kenya
Homabay County
 
21-05-2013 View